Silver in Wound Care—Friend or Foe?: A Comprehensive Review

BACKGROUND:Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, ma...

Full description

Saved in:
Bibliographic Details
Published inPlastic and reconstructive surgery. Global open Vol. 7; no. 8; p. e2390
Main Authors Khansa, Ibrahim, Schoenbrunner, Anna R., Kraft, Casey T., Janis, Jeffrey E.
Format Journal Article
LanguageEnglish
Published United States The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons 01.08.2019
Copyright The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved
Wolters Kluwer Health
Subjects
Online AccessGet full text
ISSN2169-7574
2169-7574
DOI10.1097/GOX.0000000000002390

Cover

Abstract BACKGROUND:Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines. METHODS:A search of high-quality studies on the use of silver in wound care was performed on PubMed. A detailed qualitative analysis of published articles was performed to evaluate the evidence for the use of silver in infected wounds, clean wounds, burns, and over closed surgical incisions. RESULTS:Fifty-nine studies were included in this qualitative analysis. We found that, overall, the quality of the published research on silver is poor. While there is some evidence for short-term use of dressings containing nanocrystalline silver in infected wounds, the use of silver-containing dressings in clean wounds and over closed surgical incisions is not indicated. Negative-pressure wound therapy accelerates the healing of contaminated wounds, especially when silver is used as an adjunct. For burns, silver sulfadiazine slows healing and should not be used. Instead, nanocrystalline silver, or alternatives such as octenidine and polyhexanide, lead to less infection and faster healing. CONCLUSIONS:In infected wounds, silver is beneficial for the first few days/weeks, after which nonsilver dressings should be used instead. For clean wounds and closed surgical incisions, silver confers no benefit. The ideal silver formulations are nanocrystalline silver and silver-coated polyurethane sponge for negative-pressure wound therapy. Silver sulfadiazine impairs wound healing. Proper use of silver-containing dressings is essential to optimize wound healing.
AbstractList Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines.Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines.A search of high-quality studies on the use of silver in wound care was performed on PubMed. A detailed qualitative analysis of published articles was performed to evaluate the evidence for the use of silver in infected wounds, clean wounds, burns, and over closed surgical incisions.METHODSA search of high-quality studies on the use of silver in wound care was performed on PubMed. A detailed qualitative analysis of published articles was performed to evaluate the evidence for the use of silver in infected wounds, clean wounds, burns, and over closed surgical incisions.Fifty-nine studies were included in this qualitative analysis. We found that, overall, the quality of the published research on silver is poor. While there is some evidence for short-term use of dressings containing nanocrystalline silver in infected wounds, the use of silver-containing dressings in clean wounds and over closed surgical incisions is not indicated. Negative-pressure wound therapy accelerates the healing of contaminated wounds, especially when silver is used as an adjunct. For burns, silver sulfadiazine slows healing and should not be used. Instead, nanocrystalline silver, or alternatives such as octenidine and polyhexanide, lead to less infection and faster healing.RESULTSFifty-nine studies were included in this qualitative analysis. We found that, overall, the quality of the published research on silver is poor. While there is some evidence for short-term use of dressings containing nanocrystalline silver in infected wounds, the use of silver-containing dressings in clean wounds and over closed surgical incisions is not indicated. Negative-pressure wound therapy accelerates the healing of contaminated wounds, especially when silver is used as an adjunct. For burns, silver sulfadiazine slows healing and should not be used. Instead, nanocrystalline silver, or alternatives such as octenidine and polyhexanide, lead to less infection and faster healing.In infected wounds, silver is beneficial for the first few days/weeks, after which nonsilver dressings should be used instead. For clean wounds and closed surgical incisions, silver confers no benefit. The ideal silver formulations are nanocrystalline silver and silver-coated polyurethane sponge for negative-pressure wound therapy. Silver sulfadiazine impairs wound healing. Proper use of silver-containing dressings is essential to optimize wound healing.CONCLUSIONSIn infected wounds, silver is beneficial for the first few days/weeks, after which nonsilver dressings should be used instead. For clean wounds and closed surgical incisions, silver confers no benefit. The ideal silver formulations are nanocrystalline silver and silver-coated polyurethane sponge for negative-pressure wound therapy. Silver sulfadiazine impairs wound healing. Proper use of silver-containing dressings is essential to optimize wound healing.
Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines. A search of high-quality studies on the use of silver in wound care was performed on PubMed. A detailed qualitative analysis of published articles was performed to evaluate the evidence for the use of silver in infected wounds, clean wounds, burns, and over closed surgical incisions. Fifty-nine studies were included in this qualitative analysis. We found that, overall, the quality of the published research on silver is poor. While there is some evidence for short-term use of dressings containing nanocrystalline silver in infected wounds, the use of silver-containing dressings in clean wounds and over closed surgical incisions is not indicated. Negative-pressure wound therapy accelerates the healing of contaminated wounds, especially when silver is used as an adjunct. For burns, silver sulfadiazine slows healing and should not be used. Instead, nanocrystalline silver, or alternatives such as octenidine and polyhexanide, lead to less infection and faster healing. In infected wounds, silver is beneficial for the first few days/weeks, after which nonsilver dressings should be used instead. For clean wounds and closed surgical incisions, silver confers no benefit. The ideal silver formulations are nanocrystalline silver and silver-coated polyurethane sponge for negative-pressure wound therapy. Silver sulfadiazine impairs wound healing. Proper use of silver-containing dressings is essential to optimize wound healing.
Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines.
BACKGROUND:Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting toxic effects on keratinocytes and fibroblasts. The published literature on the use of silver in wound care is very heterogeneous, making it difficult to generate useful treatment guidelines. METHODS:A search of high-quality studies on the use of silver in wound care was performed on PubMed. A detailed qualitative analysis of published articles was performed to evaluate the evidence for the use of silver in infected wounds, clean wounds, burns, and over closed surgical incisions. RESULTS:Fifty-nine studies were included in this qualitative analysis. We found that, overall, the quality of the published research on silver is poor. While there is some evidence for short-term use of dressings containing nanocrystalline silver in infected wounds, the use of silver-containing dressings in clean wounds and over closed surgical incisions is not indicated. Negative-pressure wound therapy accelerates the healing of contaminated wounds, especially when silver is used as an adjunct. For burns, silver sulfadiazine slows healing and should not be used. Instead, nanocrystalline silver, or alternatives such as octenidine and polyhexanide, lead to less infection and faster healing. CONCLUSIONS:In infected wounds, silver is beneficial for the first few days/weeks, after which nonsilver dressings should be used instead. For clean wounds and closed surgical incisions, silver confers no benefit. The ideal silver formulations are nanocrystalline silver and silver-coated polyurethane sponge for negative-pressure wound therapy. Silver sulfadiazine impairs wound healing. Proper use of silver-containing dressings is essential to optimize wound healing.
Author Khansa, Ibrahim
Schoenbrunner, Anna R.
Kraft, Casey T.
Janis, Jeffrey E.
AuthorAffiliation Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
AuthorAffiliation_xml – name: Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
Author_xml – sequence: 1
  givenname: Ibrahim
  surname: Khansa
  fullname: Khansa, Ibrahim
  organization: From the Division of Plastic and Reconstructive Surgery, Nationwide Children’s Hospital, Columbus, Ohio
– sequence: 2
  givenname: Anna R.
  surname: Schoenbrunner
  fullname: Schoenbrunner, Anna R.
  organization: Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
– sequence: 3
  givenname: Casey T.
  surname: Kraft
  fullname: Kraft, Casey T.
  organization: Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
– sequence: 4
  givenname: Jeffrey E.
  surname: Janis
  fullname: Janis, Jeffrey E.
  organization: Department of Plastic and Reconstructive Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31592393$$D View this record in MEDLINE/PubMed
BookMark eNqFkd9KHDEUxoNY6p_6BlLm0pvR_J1khFpk6dqCIGhLexeyM2fctNnJmszs4p0P4RP6JM2wKqsXGgg54Xy_74R8O2iz9S0gtE_wIcGlPDq7-HOI1xZlJd5A25QUZS6F5Jtr9Rbai_HvoFKKEyk-oi1GRJkQto2-XFm3gJDZNvvt-7bORibAw939OFhINx-ysYevx9lpNvKzeYAptNEuILuEhYXlJ_ShMS7C3uO5i36Nv_0cfc_PL85-jE7P80oUCucMVM0pLSVUzaSUhFI5wVCIitYs7YLhRmFKaqpqiQUVk5obxWrFeTP0BNtFJyvfeT-ZQV1B2wXj9DzYmQm32hurX3ZaO9XXfqELKYpC8mRw8GgQ_E0PsdMzGytwzrTg-6gpw5RLIShL0s_rs56HPP1ZEvCVoAo-xgDNs4RgPaSjUzr6dToJO36FVbYznfXDi617D1YreOldByH-c_0Sgp6Ccd30PZS_gWIiKcZlkVNMSqwSlA-gYv8BdmazWg
CitedBy_id crossref_primary_10_3390_gels9030200
crossref_primary_10_1016_j_porgcoat_2020_106091
crossref_primary_10_1007_s00772_022_00864_7
crossref_primary_10_1542_neo_22_7_e452
crossref_primary_10_1016_j_ijpharm_2021_121358
crossref_primary_10_1007_s13346_024_01716_5
crossref_primary_10_1093_jbcr_irae061
crossref_primary_10_1097_GOX_0000000000002869
crossref_primary_10_1002_aelm_202000765
crossref_primary_10_1021_acsami_3c12274
crossref_primary_10_1016_j_burns_2020_07_007
crossref_primary_10_3390_polym14101948
crossref_primary_10_1093_jbcr_irac143
crossref_primary_10_1007_s12088_023_01180_8
crossref_primary_10_3390_jpm14020206
crossref_primary_10_3390_antibiotics13090910
crossref_primary_10_5604_01_3001_0016_1101
crossref_primary_10_4274_ejbh_galenos_2024_2024_5_10
crossref_primary_10_3390_ma18030626
crossref_primary_10_1089_wound_2023_0059
crossref_primary_10_3390_pharmaceutics15082105
crossref_primary_10_3390_ph14101058
crossref_primary_10_1007_s40272_020_00434_y
crossref_primary_10_1109_TNB_2021_3105356
crossref_primary_10_7759_cureus_80189
crossref_primary_10_7759_cureus_50055
crossref_primary_10_14283_jarlife_2024_7
crossref_primary_10_1007_s10853_021_06244_y
crossref_primary_10_3389_fmolb_2022_865833
crossref_primary_10_3390_bioengineering10060711
crossref_primary_10_1093_milmed_usae166
crossref_primary_10_1128_AAC_00136_20
crossref_primary_10_3390_antiox12061176
crossref_primary_10_3390_polym15132831
crossref_primary_10_1063_5_0206812
crossref_primary_10_3390_jfb14050250
crossref_primary_10_1021_acs_molpharmaceut_0c00346
crossref_primary_10_1002_jbm_a_37527
crossref_primary_10_1016_j_molliq_2020_114575
crossref_primary_10_12968_jowc_2024_33_Sup4a_xcix
crossref_primary_10_1016_j_burnso_2024_06_003
crossref_primary_10_1097_SAP_0000000000003795
crossref_primary_10_3390_antibiotics12030536
crossref_primary_10_31083_j_fbl2903108
crossref_primary_10_3390_jfb14040234
crossref_primary_10_1093_jbcr_irac080
crossref_primary_10_12968_bjhc_2023_0030
crossref_primary_10_3390_polym12112741
crossref_primary_10_1002_jemt_24826
crossref_primary_10_3390_polym15214301
crossref_primary_10_1016_j_jddst_2022_103535
crossref_primary_10_12968_vetn_2022_13_9_411
crossref_primary_10_3390_ijms25021304
crossref_primary_10_3390_life13010069
crossref_primary_10_1111_vde_13104
crossref_primary_10_1038_s41570_023_00463_4
crossref_primary_10_3390_gels9070542
crossref_primary_10_1016_j_mycmed_2024_101519
crossref_primary_10_1093_jbcr_iraa205
crossref_primary_10_1007_s12668_024_01535_5
crossref_primary_10_12968_jowc_2020_29_Sup7_S6
crossref_primary_10_1021_acs_biomac_1c00296
crossref_primary_10_22207_JPAM_15_1_41
crossref_primary_10_3389_fbiom_2023_1285386
crossref_primary_10_1021_acs_organomet_4c00292
crossref_primary_10_1007_s40199_023_00502_x
crossref_primary_10_1093_burnst_tkac047
crossref_primary_10_3390_ijms25126610
crossref_primary_10_3390_ebj6010003
crossref_primary_10_3390_ebj6010001
crossref_primary_10_12968_vetn_2024_0056
crossref_primary_10_1016_j_mib_2021_07_001
crossref_primary_10_1016_j_polymer_2020_123353
crossref_primary_10_12968_jowc_2024_0334
crossref_primary_10_3390_nano10112318
crossref_primary_10_1002_kjm2_12940
crossref_primary_10_1093_burnst_tkab025
crossref_primary_10_1002_hsr2_641
crossref_primary_10_3390_diagnostics13071290
crossref_primary_10_3390_antiox12020467
crossref_primary_10_1097_XCS_0000000000000884
crossref_primary_10_1038_s41598_023_41572_w
crossref_primary_10_1016_j_carpta_2024_100485
crossref_primary_10_3390_gels9070591
crossref_primary_10_1038_s41598_022_19969_w
crossref_primary_10_1111_iwj_13537
crossref_primary_10_1080_15440478_2022_2150933
crossref_primary_10_3390_app12104801
crossref_primary_10_1016_j_burnso_2023_01_001
crossref_primary_10_3390_cells12010199
crossref_primary_10_3390_polym13183116
crossref_primary_10_7759_cureus_42401
crossref_primary_10_33988_auvfd_990270
crossref_primary_10_1007_s00125_022_05855_7
crossref_primary_10_56082_annalsarsciphyschem_2022_2_7
crossref_primary_10_1016_j_onano_2023_100133
crossref_primary_10_1590_1980_5373_mr_2020_0415
Cites_doi 10.1080/10408440601177665
10.1097/00024382-200014030-00013
10.1159/000481545
10.1097/01.ASW.0000434518.86905.8a
10.1016/j.burns.2014.07.024
10.1097/SAP.0b013e3181893825
10.1097/01.BCR.0000170119.87879.CA
10.1097/00000637-199706000-00001
10.1111/j.1742-481X.2010.00690.x
10.1097/BCR.0b013e318236fe31
10.1007/s11695-018-3279-8
10.12968/jowc.2016.25.3.160
10.1097/BCR.0000000000000273
10.1002/path.4360
10.1111/j.1524-475X.2011.00747.x
10.1016/j.burns.2012.04.009
10.1097/01.BCR.0000216741.21433.66
10.1016/S0140-6736(05)67695-7
10.1097/PRS.0000000000003325
10.1016/j.burns.2006.06.020
10.1016/j.burns.2014.09.012
10.1097/00129334-200510001-00001
10.1128/AAC.00001-13
10.1097/01.ASW.0000444849.71374.bc
10.1097/PRS.0b013e3182589d63
10.1111/wrr.12301
10.1097/01.ASW.0000422628.63148.4b
10.1089/sur.2013.268
10.1016/S0305-4179(01)00015-8
10.1002/bjs.6786
10.1016/S0305-4179(97)00113-7
10.1016/j.burns.2003.09.030
10.1016/j.burns.2014.11.005
10.1016/j.burns.2006.06.010
10.1111/j.1524-475X.2007.00201.x
10.1097/00004630-199807000-00002
10.1111/codi.14350
10.1016/S0305-4179(98)00095-3
10.1016/j.burns.2013.09.016
10.1186/1477-7819-10-94
10.1097/BCR.0000000000000406
10.1089/sur.2014.093
10.1111/wrr.12559
10.1016/j.injury.2013.07.014
10.1016/j.jss.2017.03.040
10.1016/j.jamcollsurg.2015.04.019
10.1016/j.arth.2018.11.017
10.1111/acem.12723
10.1007/s00595-008-3944-y
10.1016/j.jvs.2018.05.224
10.1002/bjs.1800780435
10.1016/j.burns.2016.07.004
10.1177/1534734617701051
10.12968/jowc.2012.21.2.96
10.1016/S0140-6736(75)91138-1
10.1371/journal.ppat.1003526
10.1007/s00404-015-3709-y
10.1097/00005373-198808000-00022
10.1016/j.jvs.2014.07.034
10.1016/j.burns.2009.04.008
10.4103/0970-0358.59276
10.1097/01.ASW.0000431084.85141.d1
10.4103/0976-0105.145776
10.1016/j.burns.2016.03.029
10.1097/00006534-200001000-00010
10.1016/S0168-6445(03)00047-0
ContentType Journal Article
Copyright The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved.
Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. 2019
Copyright_xml – notice: The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
– notice: Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved.
– notice: Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
– notice: Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. 2019
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1097/GOX.0000000000002390
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2169-7574
EndPage e2390
ExternalDocumentID PMC6756674
31592393
10_1097_GOX_0000000000002390
10.1097/GOX.0000000000002390
01720096-201908000-00028
Genre Journal Article
GroupedDBID 0R~
1J1
53G
5VS
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASXQ
AAUEB
ABASU
ABBUW
ABDIG
ABVCZ
ABXVJ
ABZZY
ACDDN
ACDOF
ACEWG
ACGFS
ACILI
ACLDA
ACNWC
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
ADPDF
AFBFQ
AFDTB
AFMBP
AFSOK
AFUWQ
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOIJS
AOQMC
BAWUL
BCNDV
BOYCO
BQLVK
BYPQX
DIK
DIWNM
EBS
EEVPB
ERAAH
EX3
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
HLJTE
HYE
HZ~
IKREB
IKYAY
IN~
KQ8
M48
M~E
N~7
N~B
O9-
OBH
OK1
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OXXIT
RLZ
RPM
TEORI
TSPGW
AAFWJ
AAYXX
ACCJW
ADRAZ
AFPKN
CITATION
E.X
EJD
FL-
FW0
IPNFZ
RIG
ACIJW
NPM
OVEED
7X8
ADKSD
ADSXY
5PM
ID FETCH-LOGICAL-c5680-3e8d42297ecfb971227b0e65c2d3c2d630f8021d28d70525bd4a83d844f630f53
IEDL.DBID M48
ISSN 2169-7574
IngestDate Thu Aug 21 14:03:51 EDT 2025
Mon Sep 08 15:49:55 EDT 2025
Wed Feb 19 02:13:24 EST 2025
Thu Apr 24 23:14:04 EDT 2025
Tue Jul 01 01:41:41 EDT 2025
Fri May 16 03:41:55 EDT 2025
Fri May 16 03:57:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5680-3e8d42297ecfb971227b0e65c2d3c2d630f8021d28d70525bd4a83d844f630f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1097/GOX.0000000000002390
PMID 31592393
PQID 2302475523
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6756674
proquest_miscellaneous_2302475523
pubmed_primary_31592393
crossref_primary_10_1097_GOX_0000000000002390
crossref_citationtrail_10_1097_GOX_0000000000002390
wolterskluwer_health_10_1097_GOX_0000000000002390
wolterskluwer_health_01720096-201908000-00028
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-August-01
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-August-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Plastic and reconstructive surgery. Global open
PublicationTitleAlternate Plast Reconstr Surg Glob Open
PublicationYear 2019
Publisher The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons
Copyright The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved
Wolters Kluwer Health
Publisher_xml – name: The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons
– name: Copyright The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved
– name: Wolters Kluwer Health
References Chiang (R25-20230807) 2013; 57
Gotschall (R73-20230807) 1998; 19
Vloemans (R59-20230807) 2014; 40
Ozaki (R79-20230807) 2015; 61
Warriner (R17-20230807) 2005; 18
Poon (R16-20230807) 2004; 30
Michaels (R40-20230807) 2009; 96
Barret (R61-20230807) 2000; 105
Li (R78-20230807) 2017; 215
Lansdown (R15-20230807) 2010; 2010
Abatangelo (R84-20230807) 2018; 28
Lal (R60-20230807) 2000; 14
Applewhite (R21-20230807) 2018; 30
Dumville (R77-20230807) 2016
Armstrong (R33-20230807) 2005; 366
Dumville (R9-20230807) 2015
Lazareth (R90-20230807) 2012; 21
Shah (R55-20230807) 2013; 3
O’Meara (R39-20230807) 2014
Ellenrieder (R36-20230807) 2015; 16
Lansdown (R14-20230807) 2007; 37
Stinner (R34-20230807) 2011; 71
Yarboro (R65-20230807) 2013; 26
Muangman (R68-20230807) 2006; 89
Nherera (R12-20230807) 2017; 25
Aziz (R53-20230807) 2017; 43
Cullen (R20-20230807) 2016; 7
Curran (R83-20230807) 2019; 21
Innes (R45-20230807) 2001; 27
Caruso (R70-20230807) 2006; 27
Gee Kee (R19-20230807) 2015; 41
Heyneman (R47-20230807) 2016; 42
Newman (R81-20230807) 2019; 34
Varas (R67-20230807) 2005; 26
Atiyeh (R5-20230807) 2007; 33
(R29-20230807) 2009; 9
Subrahmanyam (R88-20230807) 1991; 78
Chambers (R8-20230807) 2007; 15
Krasowski (R86-20230807) 2015; 23
Biffi (R76-20230807) 2012; 10
Abarca-Buis (R22-20230807) 2014; 27
Silverstein (R66-20230807) 2011; 32
Roy (R27-20230807) 2014; 233
Khorasani (R50-20230807) 2009; 39
Ruiz-Tovar (R80-20230807) 2015; 221
Sachsenmaier (R23-20230807) 2013; 44
Ngo (R35-20230807) 2012; 20
Drake (R13-20230807) 2005; 49
Billings (R26-20230807) 2013; 9
Godhi (R51-20230807) 2017; 7
Meekul (R31-20230807) 2017; 16
Gerding (R62-20230807) 1988; 28
Kwon (R82-20230807) 2018; 68
Silver (R6-20230807) 2003; 27
Huang (R69-20230807) 2007; 33
Stanirowski (R24-20230807) 2015; 292
Brown (R75-20230807) 2016; 37
Adhya (R18-20230807) 2014; 6
Genuino (R52-20230807) 2014; 40
Murphy (R1-20230807) 2012; 2012
Günal (R37-20230807) 2015; 16
Vieira (R85-20230807) 2018; 52
Dissemond (R10-20230807) 2017; 15
Barker (R28-20230807) 2017; 139
Abboud (R2-20230807) 2014; 40
Norman (R43-20230807) 2016
Gravante (R64-20230807) 2009; 63
Woo (R11-20230807) 2012; 25
Bergin (R41-20230807) 2006
Subrahmanyam (R89-20230807) 1998; 24
Selçuk (R74-20230807) 2012; 38
Sami (R56-20230807) 2011; 7
Oen (R46-20230807) 2012; 130
Karr (R38-20230807) 2013; 26
Morykwas (R32-20230807) 1997; 38
Wasiak (R48-20230807) 2013
Shahzad (R49-20230807) 2013; 63
Muangman (R71-20230807) 2010; 7
Kramer (R3-20230807) 2018; 31
Baghel (R54-20230807) 2009; 42
Qian (R63-20230807) 2017; 38
Bellingeri (R87-20230807) 2016; 25
Khundkar (R4-20230807) 2010; 36
McHugh (R7-20230807) 1975; 1
Mashhood (R58-20230807) 2006; 16
Vermeulen (R30-20230807) 2007
Bugmann (R72-20230807) 1998; 24
Storm-Versloot (R42-20230807) 2010
Toussaint (R44-20230807) 2015; 22
Mujalde (R57-20230807) 2014; 2
References_xml – volume: 37
  start-page: 237
  year: 2007
  ident: R14-20230807
  article-title: Critical observations on the neurotoxicity of silver.
  publication-title: Crit Rev Toxicol
  doi: 10.1080/10408440601177665
– start-page: CD005486
  year: 2007
  ident: R30-20230807
  article-title: Topical silver for treating infected wounds.
  publication-title: Cochrane Database Syst Rev
– volume: 71
  start-page: S147
  issue: suppl 1
  year: 2011
  ident: R34-20230807
  article-title: Silver dressings augment the ability of negative pressure wound therapy to reduce bacteria in a contaminated open fracture model.
  publication-title: J Trauma
– volume: 14
  start-page: 314
  year: 2000
  ident: R60-20230807
  article-title: Biobrane improves wound healing in burned children without increased risk of infection.
  publication-title: Shock
  doi: 10.1097/00024382-200014030-00013
– volume: 31
  start-page: 28
  year: 2018
  ident: R3-20230807
  article-title: Consensus on wound antisepsis: update 2018.
  publication-title: Skin Pharmacol Physiol
  doi: 10.1159/000481545
– volume: 3
  start-page: 23
  year: 2013
  ident: R55-20230807
  article-title: Effectiveness of honey dressing and silver sulfadiazine dressing on wounds healing in burn patients.
  publication-title: J Biosci Med
– volume: 9
  start-page: 1
  year: 2009
  ident: R29-20230807
  article-title: Management of chronic pressure ulcers: an evidence-based analysis.
  publication-title: Ont Health Technol Assess Ser
– volume: 26
  start-page: 562
  year: 2013
  ident: R38-20230807
  article-title: Wound healing and cost-saving benefits of combining negative-pressure wound therapy with silver.
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000434518.86905.8a
– volume: 40
  start-page: 1267
  year: 2014
  ident: R52-20230807
  article-title: Topical petrolatum gel alone versus topical silver sulfadiazine with standard gauze dressings for the treatment of superficial partial thickness burns in adults: a randomized controlled trial.
  publication-title: Burns
  doi: 10.1016/j.burns.2014.07.024
– volume: 63
  start-page: 201
  year: 2009
  ident: R64-20230807
  article-title: Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations.
  publication-title: Ann Plast Surg
  doi: 10.1097/SAP.0b013e3181893825
– volume: 26
  start-page: 344
  year: 2005
  ident: R67-20230807
  article-title: A prospective, randomized trial of acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?
  publication-title: J Burn Care Rehabil
  doi: 10.1097/01.BCR.0000170119.87879.CA
– volume: 38
  start-page: 553
  year: 1997
  ident: R32-20230807
  article-title: Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation.
  publication-title: Ann Plast Surg
  doi: 10.1097/00000637-199706000-00001
– volume: 7
  start-page: 271
  year: 2010
  ident: R71-20230807
  article-title: A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.
  publication-title: Int Wound J
  doi: 10.1111/j.1742-481X.2010.00690.x
– start-page: CD005082
  year: 2006
  ident: R41-20230807
  article-title: Silver based wound dressings and topical agents for treating diabetic foot ulcers.
  publication-title: Cochrane Database Syst Rev
– volume: 32
  start-page: 617
  year: 2011
  ident: R66-20230807
  article-title: An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream.
  publication-title: J Burn Care Res
  doi: 10.1097/BCR.0b013e318236fe31
– volume: 2010
  start-page: 910686
  year: 2010
  ident: R15-20230807
  article-title: A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.
  publication-title: Adv Pharmacol Sci
– volume: 28
  start-page: 2096
  year: 2018
  ident: R84-20230807
  article-title: Closed incision negative-pressure therapy (cinpt) reduces minor local complications in post-bariatric abdominoplasty body contouring: a retrospective case-control series.
  publication-title: Obes Surg
  doi: 10.1007/s11695-018-3279-8
– volume: 30
  start-page: S19
  issue: suppl 8
  year: 2018
  ident: R21-20230807
  article-title: Inpatient and outpatient wound treatment recommendations: assessing use of negative pressure wound therapy systems or oxidized regenerated cellulose (ORC)/ collagen/silver-ORC dressings.
  publication-title: Wounds
– volume: 25
  start-page: 160, 162
  year: 2016
  ident: R87-20230807
  article-title: Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT.
  publication-title: J Wound Care
  doi: 10.12968/jowc.2016.25.3.160
– volume: 37
  start-page: e340
  year: 2016
  ident: R75-20230807
  article-title: A randomized controlled study of silver-based burns dressing in a pediatric emergency department.
  publication-title: J Burn Care Res
  doi: 10.1097/BCR.0000000000000273
– volume: 233
  start-page: 331
  year: 2014
  ident: R27-20230807
  article-title: Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function.
  publication-title: J Pathol
  doi: 10.1002/path.4360
– volume: 20
  start-page: 83
  year: 2012
  ident: R35-20230807
  article-title: The effect of topical negative pressure on wound biofilms using an in vitro wound model.
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2011.00747.x
– start-page: CD006478
  year: 2010
  ident: R42-20230807
  article-title: Topical silver for preventing wound infection.
  publication-title: Cochrane Database Syst Rev
– volume: 38
  start-page: 1204
  year: 2012
  ident: R74-20230807
  article-title: Comparison of the antibacterial effect of silver sulfadiazine 1%, mupirocin 2%, acticoat and octenidine dihydrochloride in a full-thickness rat burn model contaminated with multi drug resistant acinetobacter baumannii.
  publication-title: Burns
  doi: 10.1016/j.burns.2012.04.009
– volume: 27
  start-page: 298
  year: 2006
  ident: R70-20230807
  article-title: Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns.
  publication-title: J Burn Care Res
  doi: 10.1097/01.BCR.0000216741.21433.66
– volume: 15
  start-page: 524
  year: 2017
  ident: R10-20230807
  article-title: Evidence for silver in wound care - meta-analysis of clinical studies from 2000-2015.
  publication-title: J Dtsch Dermatol Ges
– volume: 366
  start-page: 1704
  year: 2005
  ident: R33-20230807
  article-title: Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67695-7
– start-page: CD011277
  year: 2015
  ident: R9-20230807
  article-title: Alginate dressings for treating pressure ulcers.
  publication-title: Cochrane Database Syst Rev
– volume: 49
  start-page: 575
  year: 2005
  ident: R13-20230807
  article-title: Exposure-related health effects of silver and silver compounds: a review.
  publication-title: Ann Occup Hyg
– volume: 139
  start-page: 1184e
  year: 2017
  ident: R28-20230807
  article-title: A formidable foe is sabotaging your results: what you should know about biofilms and wound healing.
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0000000000003325
– volume: 33
  start-page: 161
  year: 2007
  ident: R69-20230807
  article-title: A randomized comparative trial between acticoat and SD-ag in the treatment of residual burn wounds, including safety analysis.
  publication-title: Burns
  doi: 10.1016/j.burns.2006.06.020
– volume: 40
  start-page: S40
  issue: suppl 1
  year: 2014
  ident: R2-20230807
  article-title: Do silver-based wound dressings reduce pain? A prospective study and review of the literature.
  publication-title: Burns
  doi: 10.1016/j.burns.2014.09.012
– volume: 18
  start-page: 2
  issue: suppl 1
  year: 2005
  ident: R17-20230807
  article-title: Infection and the chronic wound: a focus on silver.
  publication-title: Adv Skin Wound Care
  doi: 10.1097/00129334-200510001-00001
– volume: 57
  start-page: 2352
  year: 2013
  ident: R25-20230807
  article-title: Extracellular DNA shields against aminoglycosides in pseudomonas aeruginosa biofilms.
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00001-13
– volume: 7
  start-page: 10
  year: 2016
  ident: R20-20230807
  article-title: Underlying biochemistry in non-healing wounds perpetuates chronicity.
  publication-title: Wounds Int
– volume: 27
  start-page: 156
  year: 2014
  ident: R22-20230807
  article-title: Silver from polyurethane dressing is delivered by gradient to exudate, tissue, and serum of patients undergoing negative-pressure wound treatment.
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000444849.71374.bc
– volume: 130
  start-page: 274e
  year: 2012
  ident: R46-20230807
  article-title: Effectiveness of cerium nitrate-silver sulfadiazine in the treatment of facial burns: a multicenter, randomized, controlled trial.
  publication-title: Plast Reconstr Surg
  doi: 10.1097/PRS.0b013e3182589d63
– volume: 7
  start-page: 22
  year: 2011
  ident: R56-20230807
  article-title: Honey compared with silver sulphadiazine as burn wound dressing.
  publication-title: Ann Pak Inst Med Sci
– volume: 23
  start-page: 525
  year: 2015
  ident: R86-20230807
  article-title: A comparison of an antibacterial sandwich dressing vs dressing containing silver.
  publication-title: Wound Repair Regen
  doi: 10.1111/wrr.12301
– volume: 25
  start-page: 503
  year: 2012
  ident: R11-20230807
  article-title: A randomized controlled trial to evaluate an antimicrobial dressing with silver alginate powder for the management of chronic wounds exhibiting signs of critical colonization.
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000422628.63148.4b
– volume: 16
  start-page: 139
  year: 2015
  ident: R36-20230807
  article-title: Influence of antimicrobial coatings of vacuum-assisted closure dressings on methicillin-resistant staphylococcus aureus growth kinetics: an in vitro study.
  publication-title: Surg Infect (Larchmt)
  doi: 10.1089/sur.2013.268
– volume: 27
  start-page: 621
  year: 2001
  ident: R45-20230807
  article-title: The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study.
  publication-title: Burns
  doi: 10.1016/S0305-4179(01)00015-8
– volume: 7
  start-page: 57
  year: 2017
  ident: R51-20230807
  article-title: Efficacy of topical sucralfate versus silver sulfadiazine in the management of burns: a 1-year randomized controlled trial.
  publication-title: J West Afr Coll Surg
– volume: 96
  start-page: 1147
  year: 2009
  ident: R40-20230807
  article-title: Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial).
  publication-title: Br J Surg
  doi: 10.1002/bjs.6786
– volume: 24
  start-page: 157
  year: 1998
  ident: R89-20230807
  article-title: A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine.
  publication-title: Burns
  doi: 10.1016/S0305-4179(97)00113-7
– volume: 30
  start-page: 140
  year: 2004
  ident: R16-20230807
  article-title: In vitro cytotoxity of silver: implication for clinical wound care.
  publication-title: Burns
  doi: 10.1016/j.burns.2003.09.030
– volume: 41
  start-page: 946
  year: 2015
  ident: R19-20230807
  article-title: Randomized controlled trial of three burns dressings for partial thickness burns in children.
  publication-title: Burns
  doi: 10.1016/j.burns.2014.11.005
– volume: 33
  start-page: 139
  year: 2007
  ident: R5-20230807
  article-title: Effect of silver on burn wound infection control and healing: review of the literature.
  publication-title: Burns
  doi: 10.1016/j.burns.2006.06.010
– volume: 15
  start-page: 165
  year: 2007
  ident: R8-20230807
  article-title: Silver treatments for leg ulcers: a systematic review.
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2007.00201.x
– volume: 19
  start-page: 279
  year: 1998
  ident: R73-20230807
  article-title: Prospective, randomized study of the efficacy of mepitel on children with partial-thickness scalds.
  publication-title: J Burn Care Rehabil
  doi: 10.1097/00004630-199807000-00002
– volume: 21
  start-page: 110
  year: 2019
  ident: R83-20230807
  article-title: Prophylactic closed-incision negative-pressure wound therapy is associated with decreased surgical site infection in high-risk colorectal surgery laparotomy wounds.
  publication-title: Colorectal Dis
  doi: 10.1111/codi.14350
– volume: 24
  start-page: 609
  year: 1998
  ident: R72-20230807
  article-title: A silicone-coated nylon dressing reduces healing time in burned paediatric patients in comparison with standard sulfadiazine treatment: a prospective randomized trial.
  publication-title: Burns
  doi: 10.1016/S0305-4179(98)00095-3
– volume: 40
  start-page: 177
  year: 2014
  ident: R59-20230807
  article-title: Optimal treatment of partial thickness burns in children: a systematic review.
  publication-title: Burns
  doi: 10.1016/j.burns.2013.09.016
– volume: 10
  start-page: 94
  year: 2012
  ident: R76-20230807
  article-title: Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver.
  publication-title: World J Surg Oncol
  doi: 10.1186/1477-7819-10-94
– volume: 38
  start-page: e418
  year: 2017
  ident: R63-20230807
  article-title: Silver sulfadiazine retards wound healing and increases hypertrophic scarring in a rabbit ear excisional wound model.
  publication-title: J Burn Care Res
  doi: 10.1097/BCR.0000000000000406
– volume: 16
  start-page: 558
  year: 2015
  ident: R37-20230807
  article-title: The use of vacuum-assisted closure and granufoam silver® dressing in the management of diabetic foot ulcer.
  publication-title: Surg Infect (Larchmt)
  doi: 10.1089/sur.2014.093
– volume: 52
  start-page: e03393
  year: 2018
  ident: R85-20230807
  article-title: Dressings used to prevent surgical site infection in the postoperative period of cardiac surgery: integrative review.
  publication-title: Rev Esc Enferm USP
– start-page: CD003091
  year: 2016
  ident: R77-20230807
  article-title: Dressings for the prevention of surgical site infection.
  publication-title: Cochrane Database Syst Rev
– volume: 2012
  start-page: 190436
  year: 2012
  ident: R1-20230807
  article-title: Advances in wound healing: a review of current wound healing products.
  publication-title: Plast Surg Int
– volume: 25
  start-page: 707
  year: 2017
  ident: R12-20230807
  article-title: Silver delivery approaches in the management of partial thickness burns: a systematic review and indirect treatment comparison.
  publication-title: Wound Repair Regen
  doi: 10.1111/wrr.12559
– volume: 44
  start-page: 1363
  year: 2013
  ident: R23-20230807
  article-title: Antibacterial potency of V.A.C. Granufoam silver(®) dressing.
  publication-title: Injury
  doi: 10.1016/j.injury.2013.07.014
– volume: 215
  start-page: 98
  year: 2017
  ident: R78-20230807
  article-title: Silver-containing dressing for surgical site infection in clean and clean-contaminated operations: a systematic review and meta-analysis of randomized controlled trials.
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2017.03.040
– volume: 221
  start-page: 424
  year: 2015
  ident: R80-20230807
  article-title: Total occlusive ionic silver-containing dressing vs mupirocin ointment application vs conventional dressing in elective colorectal surgery: effect on incisional surgical site infection.
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2015.04.019
– volume: 34
  start-page: 554
  year: 2019
  ident: R81-20230807
  article-title: Use of closed incisional negative pressure wound therapy after revision total hip and knee arthroplasty in patients at high risk for infection: a prospective, randomized clinical trial.
  publication-title: J Arthroplasty
  doi: 10.1016/j.arth.2018.11.017
– volume: 22
  start-page: 927
  year: 2015
  ident: R44-20230807
  article-title: Topical antibiotic ointment versus silver-containing foam dressing for second-degree burns in swine.
  publication-title: Acad Emerg Med
  doi: 10.1111/acem.12723
– volume: 39
  start-page: 587
  year: 2009
  ident: R50-20230807
  article-title: Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study.
  publication-title: Surg Today
  doi: 10.1007/s00595-008-3944-y
– volume: 68
  start-page: 1744
  year: 2018
  ident: R82-20230807
  article-title: A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications.
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2018.05.224
– volume: 78
  start-page: 497
  year: 1991
  ident: R88-20230807
  article-title: Topical application of honey in treatment of burns.
  publication-title: Br J Surg
  doi: 10.1002/bjs.1800780435
– volume: 43
  start-page: 50
  year: 2017
  ident: R53-20230807
  article-title: The effects of honey compared to silver sulfadiazine for the treatment of burns: a systematic review of randomized controlled trials.
  publication-title: Burns
  doi: 10.1016/j.burns.2016.07.004
– start-page: CD002106
  year: 2013
  ident: R48-20230807
  article-title: Dressings for superficial and partial thickness burns.
  publication-title: Cochrane Database Syst Rev
– volume: 16
  start-page: 108
  year: 2017
  ident: R31-20230807
  article-title: A randomized controlled trial on the outcome in comparing an alginate silver dressing with a conventional treatment of a necrotizing fasciitis wound.
  publication-title: Int J Low Extrem Wounds
  doi: 10.1177/1534734617701051
– volume: 16
  start-page: 14
  year: 2006
  ident: R58-20230807
  article-title: Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns.
  publication-title: J Pak Assoc Derma
– start-page: CD011586
  year: 2016
  ident: R43-20230807
  article-title: Antibiotics and antiseptics for pressure ulcers.
  publication-title: Cochrane Database Syst Rev
– volume: 21
  start-page: 96
  year: 2012
  ident: R90-20230807
  article-title: Efficacy of a silver lipidocolloid dressing on heavily colonised wounds: a republished RCT.
  publication-title: J Wound Care
  doi: 10.12968/jowc.2012.21.2.96
– volume: 63
  start-page: 225
  year: 2013
  ident: R49-20230807
  article-title: Effectiveness of aloe vera gel compared with 1% silver sulphadiazine cream as burn wound dressing in second degree burns.
  publication-title: J Pak Med Assoc
– volume: 1
  start-page: 235
  year: 1975
  ident: R7-20230807
  article-title: Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(75)91138-1
– volume: 9
  start-page: e1003526
  year: 2013
  ident: R26-20230807
  article-title: The extracellular matrix component psl provides fast-acting antibiotic defense in pseudomonas aeruginosa biofilms.
  publication-title: Plos Pathog
  doi: 10.1371/journal.ppat.1003526
– volume: 292
  start-page: 757
  year: 2015
  ident: R24-20230807
  article-title: Growth factors, silver dressings and negative pressure wound therapy in the management of hard-to-heal postoperative wounds in obstetrics and gynecology: a review.
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-015-3709-y
– volume: 2
  start-page: 193
  issue: 1B
  year: 2014
  ident: R57-20230807
  article-title: To assess the efficacy of honey in comparison with 1% silver sulfadiazine cream as a burn wound dressing in superficial and partial thickness of burns.
  publication-title: Sch J App Med Sci
– volume: 28
  start-page: 1265
  year: 1988
  ident: R62-20230807
  article-title: Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns.
  publication-title: J Trauma
  doi: 10.1097/00005373-198808000-00022
– volume: 61
  start-page: 419
  year: 2015
  ident: R79-20230807
  article-title: Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications.
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2014.07.034
– volume: 36
  start-page: 751
  year: 2010
  ident: R4-20230807
  article-title: Use of acticoat dressings in burns: what is the evidence?
  publication-title: Burns
  doi: 10.1016/j.burns.2009.04.008
– volume: 42
  start-page: 176
  year: 2009
  ident: R54-20230807
  article-title: A comparative study to evaluate the effect of honey dressing and silver sulfadiazene dressing on wound healing in burn patients.
  publication-title: Indian J Plast Surg
  doi: 10.4103/0970-0358.59276
– volume: 26
  start-page: 259
  year: 2013
  ident: R65-20230807
  article-title: A comparative study of the dressings silver sulfadiazine and Aquacel Ag in the management of superficial partial-thickness burns.
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000431084.85141.d1
– volume: 6
  start-page: 29
  year: 2014
  ident: R18-20230807
  article-title: Healing of burn wounds by topical treatment: a randomized controlled comparison between silver sulfadiazine and nano-crystalline silver.
  publication-title: J Basic Clin Pharm
  doi: 10.4103/0976-0105.145776
– start-page: CD003557
  year: 2014
  ident: R39-20230807
  article-title: Antibiotics and antiseptics for venous leg ulcers.
  publication-title: Cochrane Database Syst Rev
– volume: 42
  start-page: 1377
  year: 2016
  ident: R47-20230807
  article-title: The role of silver sulphadiazine in the conservative treatment of partial thickness burn wounds: a systematic review.
  publication-title: Burns
  doi: 10.1016/j.burns.2016.03.029
– volume: 89
  start-page: 953
  year: 2006
  ident: R68-20230807
  article-title: Comparison of efficacy of 1% silver sulfadiazine and acticoat for treatment of partial-thickness burn wounds.
  publication-title: J Med Assoc Thai
– volume: 105
  start-page: 62
  year: 2000
  ident: R61-20230807
  article-title: Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns.
  publication-title: Plast Reconstr Surg
  doi: 10.1097/00006534-200001000-00010
– volume: 27
  start-page: 341
  year: 2003
  ident: R6-20230807
  article-title: Bacterial silver resistance: molecular biology and uses and misuses of silver compounds.
  publication-title: FEMS Microbiol Rev
  doi: 10.1016/S0168-6445(03)00047-0
SSID ssj0000884175
Score 2.4674242
Snippet BACKGROUND:Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by...
Due to its strong antimicrobial activity, silver is a commonly used adjunct in wound care. However, it also has the potential to impair healing by exerting...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e2390
SubjectTerms Special Topic
Title Silver in Wound Care—Friend or Foe?: A Comprehensive Review
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01720096-201908000-00028
https://www.ncbi.nlm.nih.gov/pubmed/31592393
https://www.proquest.com/docview/2302475523
https://pubmed.ncbi.nlm.nih.gov/PMC6756674
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6S7aUQSksfcdoGFXJ1sSVZj8ISQuk2FNockqV7M2tLIksWO9lNaHvLj8gv7C_pjB9Lt0lbYvDFkmV7JI2-8Yy-AdhDyB2SEMrY4nCKpXE2nhYujYPwwZeuRPVAHt3PX9ThWH6aZJMN6HO2dgJc3mnaUT6p8WL-9vvFj32c8MOegPHj0aSlIewOjnb8JjxoPEYUzNcB_kY3GyPThn2Xp8rGOtOy30_3l4bW16tbIPR2LOXWt5r83MuzJsz9t8Vq9BgedSiTHbTD4gls-OopDI9nFAbNZhX7SsmUGO09-nl9MyKqY8fqBRvVfv8dO2CkJBb-tI1tZ6374BmMRx9O3h_GXfaEuMyUQeXqjZOcW-3LUFidcq6LxKus5E7gqUQSDC7wjhunKZld4eTUCGekDFSWiecwqOrKbwPz2lnhrbOJLKQSblokwvnShqC8RAgRgehllJcdtThluJjnvYsbJZv_KdkI4tVd5y21xn_qv-nFn-McIMfGtPL11TJHM4pLnaFNHcGLtjtWLQrEa0TzFoFe66hVBeLXXi-pZqcNzzbaUkppie-51qV5u0M1J-uZLEBUNIiqEHg3W_S5iSC9s_6_vm3nns94CQ_pShuJ-AoGl4sr_xrR0WWx2_xV2G2G_S9hXwOt
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silver+in+Wound+Care%E2%80%94Friend+or+Foe%3F%3A+A+Comprehensive+Review&rft.jtitle=Plastic+and+reconstructive+surgery.+Global+open&rft.au=Khansa%2C+Ibrahim&rft.au=Schoenbrunner%2C+Anna+R.&rft.au=Kraft%2C+Casey+T.&rft.au=Janis%2C+Jeffrey+E.&rft.date=2019-08-01&rft.pub=The+Authors.+Published+by+Wolters+Kluwer+Health%2C+Inc.+on+behalf+of+The+American+Society+of+Plastic+Surgeons&rft.issn=2169-7574&rft.eissn=2169-7574&rft.volume=7&rft.issue=8&rft.spage=e2390&rft.epage=e2390&rft_id=info:doi/10.1097%2FGOX.0000000000002390&rft.externalDocID=01720096-201908000-00028
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2169-7574&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2169-7574&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2169-7574&client=summon